Sunandana Chandra

Case Report: Exceptional response to perioperative pembrolizumab in UV-signature melanoma of unknown primary presenting as an isolated pulmonary metastasis

Austin Drysch, Genti Gjyzeli, Paul Buttars, Sunandana Chandra et autres

us (code pays fourni par la source)

Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma

Bina Kassamali, Jonathan D. Schoenfeld, Rosh Sethi, R H Bakst et autres

us (code pays fourni par la source)

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti–PD-1 Therapy

Megan Othus, Thach‐Giao Truong, Elad Sharon, Kari Kendra et autres

Afrique du Sud, us, ca (code pays fourni par la source)

Supplementary Tables S1-S36 from Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy

Zachary Z. Reinstein, Yue Zhang, Oscar E. Ospina, Matt D. Nichols et autres

Supplementary Figures S1-S25 from Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy

Zachary Z. Reinstein, Yue Zhang, Oscar E. Ospina, Matt D. Nichols et autres

ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in patients with Merkel cell carcinoma and lymph node metastases.

Shailender Bhatia, T Gooley, Andrew S. Brohl, Leslie A. Fecher et autres

us (code pays fourni par la source)

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology

Susan M. Swetter, Douglas Johnson, Mark R. Albertini, C. A. Barker et autres

in, us, Afrique du Sud (code pays fourni par la source)

A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor–naïve patients with metastatic uveal melanoma.

Marlana Orloff, Justin C. Moser, Alexander Shoushtari, Allison Betof et autres

us, au, de, gb (code pays fourni par la source)

Results from a phase 2a study of atebimetinib in combination with mGnP in advanced or metastatic pancreatic cancer.

Vincent Chung, Peter Vu, T. Vincent, N. Uboha et autres

us (code pays fourni par la source)

TIL cell therapy in HIV positive patient with metastatic melanoma: case report

Brian Whetsell, Juan Alban, A LIN, Jeffrey D. Wayne et autres

us (code pays fourni par la source)

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study

Guilherme Rabinowits, Soo J. Park, Nikhil I. Khushalani, Timothy Panella et autres

us, pr, jp (code pays fourni par la source)

Response to Gao and Chen, “Comments on Akaike et al’s ‘Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management’”

Tomoko Akaike, Manisha Thakuria, Ann W. Silk, Daniel S. Hippe et autres

us (code pays fourni par la source)